Evidence map›Paper›PMID 38528760›Full record

ArticleDiagnostic and interventional radiology (Ankara, Turkey)2024

Value of perfusion parameters from golden-angle radial sparse parallel dynamic contrast-enhanced magnetic resonance imaging in predicting pathological complete response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer

Yu-Ning Pan, Meng-Yin Gu, Quan-Liang Mao, Yu-Guo Wei, Lin Zhang, Guang-Yu Tang

Open access · diamondAbstract read
In one paragraph

Article in Diagnostic and interventional radiology (Ankara, Turkey), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Guideline
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Yu-Ning PanShanghai Tenth People’s Hospital of Tongji University, Department of Radiology, Shanghai, ChinaORCID 0000-0002-9010-078X
Meng-Yin GuNingbo University, Department of Medical College, Ningbo, ChinaORCID 0000-0002-7127-0812
Quan-Liang MaoThe First Affiliated Hospital of Ningbo University, Department of Radiology, Ningbo, ChinaORCID 0000-0002-3579-0909
Yu-Guo WeiGE Healthcare, Global Medical Service, Advanced Analytics, Hangzhou, ChinaORCID 0000-0002-5352-3062
Lin ZhangShanghai Tenth People’s Hospital of Tongji University, Department of Radiology, Shanghai, ChinaORCID 0009-0007-1209-7726
Guang-Yu TangShanghai Tenth People’s Hospital of Tongji University, Department of Radiology, Shanghai, ChinaORCID 0000-0003-4181-3318
Tongji University · CNNingbo University · CNUniversity of Nottingham Ningbo China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeNon-invasive methods for predicting pathological complete response (pCR) after neoadjuvant chemoradiotherapy (nCRT) can provide distinct leverage in the management of patients with locally advanced rectal cancer (LARC). This study aimed to investigate whether including the golden-angle radial sparse parallel (GRASP) dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) perfusion parameter (K

methodsPatients with LARC who underwent nCRT and subsequent surgery were included. The imaging parameters were compared between patients with and without pCR. Receiver operating characteristic (ROC) curve analysis was used to evaluate the predictive ability of these parameters for pCR.

resultsA total of 111 patients were included in the study. A pCR was obtained in 32 patients (28.8%). MRI-based TRG (mrTRG) showed a negative correlation with pCR (r = -0.61,

conclusionThe use of a combination of the GRASP DCE-MRI K

Indexed as

Contrast MediaMagnetic Resonance ImagingNeoadjuvant TherapyRectal NeoplasmsAdultAgedChemoradiotherapyFemaleHumansMaleMiddle AgedPredictive Value of TestsRetrospective StudiesROC CurveTreatment OutcomeContrast Mediacomplete responselocally advancedmagnetic resonance imagingneoadjuvant chemoradiotherapyRectal cancertumor regression grading

Identifiers

PMID38528760
PMCPMC11589510
OpenAlexW4393195276

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.